ARCHIVES

Oncotype DX Cancer Test Can Predict Recurrence

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Issues MedWatch Warning, Begins Safety Review Of Prostate Cancer Drugs

May 7, 2010

Six More Clinical Trials Proposed For High Priority Status, But Per Case Funds For Them Not Assured

June 16, 1989

Concept Approval Given To $7 Million In OD Recompetitions, Renewals

May 28, 1982

The New NCI: Structure, Procedures, Advisory Boards To Change, Klausner Says

September 15, 1995

Obama Picks Hamburg for FDA Commissioner

March 20, 2009

Congressional Committee, SEC Probe ImClone’s Statements To Shareholders.

January 25, 2002